TY - JOUR
T1 - Regulation of tumor–stroma interactions by the unfolded protein response
AU - Obacz, Joanna
AU - Avril, Tony
AU - Rubio-Patiño, Camila
AU - Bossowski, Jozef P.
AU - Igbaria, Aeid
AU - Ricci, Jean Ehrland
AU - Chevet, Eric
N1 - Funding Information:
This work was funded by grants from Institut National du Cancer (INCa; PLBIO: 2017, PLBIO: 2015-111, INCA_7981), and Ligue Contre le Cancer, EU H2020 MSCA ITN-675448 (TRAINERS) and MSCA RISE-734749 (INSPIRED) to EC; Fondation ARC pour la Recherche sur le Cancer and the Agence Nationale de la Recherche (LABEX SIGNALIFE ANR-11-LABX-0028-01) to JER; Juvenile Diabetes Research Foundation (JDRF 3-PDF-2015-80-A-N) to AI.
Publisher Copyright:
© 2017 Federation of European Biochemical Societies
PY - 2019/1
Y1 - 2019/1
N2 - The unfolded protein response (UPR) is a conserved adaptive pathway that helps cells cope with the protein misfolding burden within the endoplasmic reticulum (ER). Imbalance between protein folding demand and capacity in the ER leads to a situation called ER stress that is often observed in highly proliferative and secretory tumor cells. As such, activation of the UPR signaling has emerged as a key adaptive mechanism promoting cancer progression. It is becoming widely acknowledged that, in addition to its intrinsic effect on tumor biology, the UPR can also regulate tumor microenvironment. In this review, we discuss how the UPR coordinates the crosstalk between tumor and stromal cells, such as endothelial cells, normal parenchymal cells, and immune cells. In addition, we further describe the involvement of ER stress signaling in the response to current treatments as well as its impact on antitumor immunity mainly driven by immunogenic cell death. Finally, in this context, we discuss the relevance of targeting ER stress/UPR signaling as a potential anticancer approach.
AB - The unfolded protein response (UPR) is a conserved adaptive pathway that helps cells cope with the protein misfolding burden within the endoplasmic reticulum (ER). Imbalance between protein folding demand and capacity in the ER leads to a situation called ER stress that is often observed in highly proliferative and secretory tumor cells. As such, activation of the UPR signaling has emerged as a key adaptive mechanism promoting cancer progression. It is becoming widely acknowledged that, in addition to its intrinsic effect on tumor biology, the UPR can also regulate tumor microenvironment. In this review, we discuss how the UPR coordinates the crosstalk between tumor and stromal cells, such as endothelial cells, normal parenchymal cells, and immune cells. In addition, we further describe the involvement of ER stress signaling in the response to current treatments as well as its impact on antitumor immunity mainly driven by immunogenic cell death. Finally, in this context, we discuss the relevance of targeting ER stress/UPR signaling as a potential anticancer approach.
KW - ER stress
KW - immunogenic cell death
KW - inflammation
KW - tumor microenvironment
KW - unfolded protein response
UR - http://www.scopus.com/inward/record.url?scp=85042941761&partnerID=8YFLogxK
U2 - 10.1111/febs.14359
DO - 10.1111/febs.14359
M3 - Review article
C2 - 29239107
AN - SCOPUS:85042941761
VL - 286
SP - 279
EP - 296
JO - FEBS Journal
JF - FEBS Journal
SN - 1742-464X
IS - 2
ER -